Action of Modafinil-Increased Motivation Via the Dopamine Transporter Inhibition and D1 Receptors?

Biological Psychiatry

Volumn 67, Issue 8, 2010, Pages 784-787

  Young, Jared W ^a   Geyer, Mark A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

D1 receptor; dopamine transporter; knockout; mice; Modafinil; motivation

Indexed keywords

DOPAMINE 1 RECEPTOR; DOPAMINE TRANSPORTER; MODAFINIL; VANOXERINE;

ANIMAL EXPERIMENT; ARTICLE; BEHAVIOR; COGNITION; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; FEMALE; KNOCKOUT MOUSE; MALE; MOTIVATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; TASK PERFORMANCE; WILD TYPE;

ANIMALS; BENZHYDRYL COMPOUNDS; CENTRAL NERVOUS SYSTEM STIMULANTS; CONDITIONING, OPERANT; DOPAMINE PLASMA MEMBRANE TRANSPORT PROTEINS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; MALE; MICE; MICE, KNOCKOUT; MOTIVATION; PIPERAZINES; PSYCHOMOTOR PERFORMANCE; RECEPTORS, DOPAMINE D1; REINFORCEMENT SCHEDULE;

EID: 77950020289     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2009.12.015     Document Type: Article

References (20)

1. Minzenberg M.J., and Carter C.S. Modafinil: A review of neurochemical actions and effects on cognition. Neuropsychopharmacology 33 (2008) 1477-1502
2. Wu P., Jones S., Ryan C.J., Michail D., and Robinson T.D. Modafinil-induced psychosis. Intern Med J 38 (2008) 677-678
3. Mignot E., Nishino S., Guilleminault C., and Dement W.C. Modafinil binds to the dopamine uptake carrier site with low affinity. Sleep 17 (1994) 436-437
4. Madras B.K., Xie Z., Lin Z., Jassen A., Panas H., Lynch L., et al. Modafinil occupies dopamine and norepinephrine transporters in vivo and modulates the transporters and trace amine activity in vitro. J Pharmacol Exp Ther 319 (2006) 561-569
5. Volkow N.D., Fowler J.S., Logan J., Alexoff D., Zhu W., Telang F., et al. Effects of modafinil on dopamine and dopamine transporters in the male human brain: Clinical implications. JAMA 301 (2009) 1148-1154
6. Wisor J.P., Nishino S., Sora I., Uhl G.H., Mignot E., and Edgar D.M. Dopaminergic role in stimulant-induced wakefulness. J Neurosci 21 (2001) 1787-1794
7. Qu W.M., Huang Z.L., Xu X.H., Matsumoto N., and Urade Y. Dopaminergic D1 and D2 receptors are essential for the arousal effect of modafinil. J Neurosci 28 (2008) 8462-8469
8. Zolkowska D., Jain R., Rothman R.B., Partilla J.S., Roth B.L., Setola V., et al. Evidence for the involvement of dopamine transporters in behavioral stimulant effects of modafinil. J Pharmacol Exp Ther 329 (2009) 738-746
9. Turner D.C., Clark L., Pomarol-Clotet E., McKenna P., Robbins T.W., and Sahakian B.J. Modafinil improves cognition and attentional set shifting in patients with chronic schizophrenia. Neuropsychopharmacology 29 (2004) 1363-1373
10. Faerden A., Vaskinn A., Finset A., Agartz I., Ann B.E., Friis S., et al. Apathy is associated with executive functioning in first episode psychosis. BMC Psychiatry 9 (2009) 1
11. Bensadoun J.C., Brooks S.P., and Dunnett S.B. Free operant and discrete trial performance of mice in the nine-hole box apparatus: Validation using amphetamine and scopolamine. Psychopharmacology 174 (2004) 396-405
12. El-Ghundi M., O'Dowd B.F., Erclik M., and George S.R. Attenuation of sucrose reinforcement in dopamine D1 receptor deficient mice. Eur J Neurosci 17 (2003) 851-862
13. Han D.D., and Gu H.H. Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs. BMC Pharmacol 6 (2006) 6
14. Stoops W.W., Lile J.A., Fillmore M.T., Glaser P.E., and Rush C.R. Reinforcing effects of modafinil: Influence of dose and behavioral demands following drug administration. Psychopharmacology 182 (2005) 186-193
15. Wisor J.P., and Eriksson K.S. Dopaminergic-adrenergic interactions in the wake promoting mechanism of modafinil. Neuroscience 132 (2005) 1027-1034
16. Von Huben S.N., Davis S.A., Lay C.C., Katner S.N., Crean R.D., and Taffe M.A. Differential contributions of dopaminergic D1- and D2-like receptors to cognitive function in rhesus monkeys. Psychopharmacology 188 (2006) 586-596
17. Cetin T., Freudenberg F., Fuchtemeier M., and Koch M. Dopamine in the orbitofrontal cortex regulates operant responding under a progressive ratio of reinforcement in rats. Neurosci Lett 370 (2004) 114-117
18. Caine S.B., Thomsen M., Gabriel K.I., Berkowitz J.S., Gold L.H., Koob G.F., et al. Lack of self-administration of cocaine in dopamine D1 receptor knock-out mice. J Neurosci 27 (2007) 13140-13150
19. El-Ghundi M., Fletcher P.J., Drago J., Sibley D.R., O'Dowd B.F., and George S.R. Spatial learning deficit in dopamine D(1) receptor knockout mice. Eur J Pharmacol 383 (1999) 95-106
20. Young J.W., Goey A., Minassian A., Perry W., Paulus M.P., and Geyer M.A. GBR 12909 administration as a mouse model of bipolar disorder mania: Mimicking quantitative assessment of manic behavior. Psychopharmacology (Berl) 208 (2010) 443-454